logo

For the Inventor, By the Inventor

Kanagawa, Japan

Peptidream Inc.

Calculating rank
USPTO Granted Patents = 12



Trademarks = 3

Forward Citations = 16

Loading Chart...
Loading Chart...

37 inventors (with patents filed for the assignee):

goldMedal Patrick Reid (7 out of 10 patents)

silverMedal Keiichi Masuya (4 out of 4 patents)

bronzeMedal Takashi Kawakami (3 out of 54 patents)

4.  Hiroshi Murakami (3 out of 29 patents)

5.  Masaki Ohuchi (3 out of 4 patents)

6.  Michiharu Handa (3 out of 4 patents)

7.  Michinori Kohara (2 out of 19 patents)

8.  Toru Sasaki (2 out of 88 patents)

9.  Kiichi Kubota (2 out of 2 patents)

10.  Akihiro Nagaya (2 out of 5 patents)

11.  Yoshiaki Masuda (1 out of 37 patents)

12.  Takahiro Yamaguchi (1 out of 141 patents)

13.  Yutaka Mori (1 out of 9 patents)

14.  Hideki Kubota (1 out of 20 patents)

15.  Hironao Saito (1 out of 4 patents)


12 patents:

1. 12528834 - Method for producing peptide compound (2026-01-20),
2. 12415834 - GhR-binding peptide and composition comprising same (2025-09-16),
3. 12351652 - Hemagglutinin-binding peptide (2025-07-08),
4. 12240871 - Method for producing peptide compound (2025-03-04),
5. 11993629 - Method for producing peptide compound (2024-05-28),
6. 11970694 - Rapid display method in translational synthesis of peptide (2024-04-30),
7. 11149066 - Thrombospondin 1-binding peptide (2021-10-19),
8. 10745692 - Production method for charged non-protein amino acid-containing peptide (2020-08-18),
9. 10711268 - Method for producing peptide library, peptide library, and screening method (2020-07-14),
10. 10632187 - Hemagglutinin-binding peptide (2020-04-28),
11. 10328143 - Hemagglutinin-binding peptide (2019-06-25),
12. 9815867 - Peptide for inhibiting vascular endothelial growth factor receptor (2017-11-14),
Company Overview
Peptidream Inc. is a biopharmaceutical company based in Kanagawa, Japan, specializing in the discovery and development of peptide-based therapeutics. The company leverages its proprietary Peptide Discovery Platform Technology (PDPT) to create novel peptides that can be utilized in various therapeutic areas, including oncology and metabolic diseases. Peptidream's innovative approach focuses on enhancing the efficacy and specificity of peptide drugs, positioning it as a key player in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#139 in Kanagawa

#3,938 in Japan

#48,235 in the World

Kanagawa, JP
Kanagawa, Japan

Peptidream Inc.

Forward Citations = 16

37 inventors:

goldMedal Patrick Reid (7 out of 10 patents)

silverMedal Keiichi Masuya (4 out of 4 patents)

bronzeMedal Takashi Kawakami (3 out of 54 patents)

4.  Hiroshi Murakami (3 out of 29 patents)

5.  Masaki Ohuchi (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Peptidream Inc.. Retrieved from https://idiyas.com/company/peptidream

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…